Pharmazeutische Referenzstandards

USP-1000521

[56180-94-0]

200 mg

C25H43NO18

USP-1012101

[73-24-5]

200 mg

C5H5N5

USP-1043003

[50-81-7]

1 g

C6H8O6

USP-1086200

[47931-85-1]

40 mg

C145H240N44O48S2

USP-1148001

[1264-72-8]

200 mg

Compound A: C53H100N16O13 • (H2SO4) Compound B: C52H98N16O13 • (H2SO4)

USP-1148089

[9001-12-1]

2 x 0,5 mL

113897 daltons / for beta subtype

USP-1173202

[62288-83-9]

1,75 mg

C46H64N14O12S2 · CH3CO2H

USP-1203008

[5490-27-7]

200 mg

C21H41N7O12 · 3/2H2SO4

USP-1235503

[n/a]

11000 USP Endotoxin Units

/

USP-1282742

0,5 mL

USP-1303750

[9008-02-0]

100 g

C2964H4482N778O816S12Fe4

USP-1304038

[9041-08-1]

50 mg

/

USP-1365000

[51-48-9]

250 mg

C15H11I4NO4

USP-1368008

[6893-02-3]

250 mg

C15H12I3NO4

USP-1477003

[1400-61-9]

200 mg

C47H75NO17

USP-1500003

[1263-89-4]

125 mg

C23H45N5O14 · xH2SO4

USP-1502508

[113-98-4]

200 mg

C16H17KN2O4S

USP-1615708

[12629-01-5]

vial

C990H1528N262O300S7

USP-1696110

[102992-39-2]

1,23 mg

C64H82N18O

USP-1696128

[321709-35-7]

1,68 mg

C64H82N18O13

USP-1696142

[129418-54-8]

1,31 mg

C64H81N17O14

USP-1700013

[9002-07-7]

2 x 1 mL

C1020H1597N287=321S14

USP-1800255

each

USP-1800256

each

USP-1800260

each

USP-1800262

each

USP-1800494

each